NasdaqGS - Nasdaq Real Time Price USD
Precigen, Inc. (PGEN)
1.5900
-0.0300
(-1.85%)
At close: April 24 at 4:00:00 PM EDT
1.6600
+0.07
+(4.40%)
After hours: April 24 at 7:59:33 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-68,173
-68,173
-66,930
-65,045
-55,771
Investing Cash Flow
-20,714
-20,714
-3,087
226,417
-74,540
Financing Cash Flow
110,583
110,583
29,589
-155,292
121,187
End Cash Position
29,517
29,517
7,848
48,596
43,343
Income Tax Paid Supplemental Data
4
4
21
--
36
Interest Paid Supplemental Data
7
7
1,171
8,535
7,155
Capital Expenditure
-8,584
-8,584
-1,536
-4,924
-7,247
Issuance of Capital Stock
110,237
110,237
72,808
--
121,045
Repayment of Debt
--
--
-43,219
-155,293
-466
Free Cash Flow
-76,757
-76,757
-68,466
-69,969
-63,018
12/31/2021 - 8/8/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TCRT Alaunos Therapeutics, Inc.
2.6800
+8.94%
SGMO Sangamo Therapeutics, Inc.
0.8149
+8.06%
INO Inovio Pharmaceuticals, Inc.
1.9200
+2.67%
GOSS Gossamer Bio, Inc.
0.9792
+9.43%
CLDX Celldex Therapeutics, Inc.
19.58
+0.77%
ABEO Abeona Therapeutics Inc.
5.39
+3.26%
HALO Halozyme Therapeutics, Inc.
59.25
+1.44%
MGNX MacroGenics, Inc.
1.7900
+4.68%
FATE Fate Therapeutics, Inc.
1.3500
+1.50%
VSTM Verastem, Inc.
7.50
+5.34%